NovMetaPharma Co., Ltd. (XKON:229500)
3,570.00
-210.00 (-5.56%)
At close: Nov 6, 2026
| Market Cap | 45.84B -71.9% |
| Revenue (ttm) | 1.30B +21.4% |
| Net Income | 408.03M |
| EPS | 120.00 |
| Shares Out | 12.84M |
| PE Ratio | 29.75 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,724 |
| Open | 3,840.00 |
| Previous Close | 3,780.00 |
| Day's Range | 3,400.00 - 3,840.00 |
| 52-Week Range | 3,280.00 - 15,600.00 |
| Beta | 0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |